1. Home
  2. MBIO vs ZCMD Comparison

MBIO vs ZCMD Comparison

Compare MBIO & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.71

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Logo Zhongchao Inc.

ZCMD

Zhongchao Inc.

N/A

Current Price

$1.78

Market Cap

6.9M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
MBIO
ZCMD
Founded
2015
2012
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
6.9M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
MBIO
ZCMD
Price
$0.71
$1.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.0K
21.8K
Earning Date
03-19-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
98.99
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.18
52 Week High
$7.00
$1.95

Technical Indicators

Market Signals
Indicator
MBIO
ZCMD
Relative Strength Index (RSI) 28.85 68.14
Support Level $0.53 $1.02
Resistance Level $1.00 $1.94
Average True Range (ATR) 0.06 0.18
MACD -0.02 -0.04
Stochastic Oscillator 9.18 77.23

Price Performance

Historical Comparison
MBIO
ZCMD

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

Share on Social Networks: